BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu M, Luo C, Xie ZZ, Li X. Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report. World J Clin Cases 2022; 10(16): 5420-5427 [PMID: 35812689 DOI: 10.12998/wjcc.v10.i16.5420]
URL: https://www.wjgnet.com/2307-8960/full/v10/i16/5420.htm
Number Citing Articles
1
Ming Li, Yan-Xia Mei, Ji-Hang Wen, Yu-Rong Jiao, Qiang-Rong Pan, Xiang-Xing Kong, Jun Li. Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristicsCancer Letters 2023; 559: 216104 doi: 10.1016/j.canlet.2023.216104
2
AntineoplasticsReactions Weekly 2022; 1916(1): 53 doi: 10.1007/s40278-022-19512-1
3
Yi-Jun Mo, Li-Na Lin, Jing-Li Tao, Tao Zhang, Jian-Hua Zhang. Hepatoid adenocarcinoma of the lung: A case reportWorld Journal of Clinical Cases 2024; 12(21): 4813-4819 doi: 10.12998/wjcc.v12.i21.4813